IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$415M
AUM Growth
+$35.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
76
New
Increased
Reduced
Closed

Top Buys

1 +$14.4M
2 +$14.3M
3 +$10.9M
4
INCY icon
Incyte
INCY
+$9.18M
5
TVTX icon
Travere Therapeutics
TVTX
+$8.73M

Top Sells

1 +$17.8M
2 +$14M
3 +$7.77M
4
XLRN
Acceleron Pharma
XLRN
+$7.59M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$6.81M

Sector Composition

1 Healthcare 98.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
51
$1.25M 0.3%
21,000
52
$1.2M 0.29%
4,467
53
$1.1M 0.27%
53,000
54
$1.02M 0.25%
10,700
55
$992K 0.24%
21,500
56
$904K 0.22%
94,600
57
$564K 0.14%
16,600
-83,400
58
$555K 0.13%
21,800
59
$521K 0.13%
60,000
60
$461K 0.11%
14,000
61
$418K 0.1%
107,000
62
$388K 0.09%
25,500
63
$371K 0.09%
44,000
64
$271K 0.07%
10,000
65
$261K 0.06%
+10,000
66
$210K 0.05%
849
67
$201K 0.05%
788
68
$114K 0.03%
9,500
69
-23,400
70
-78,000
71
-82,633
72
-152,000
73
-31,500
74
-43,300
75
-60,500